LifeMD (LFMD) News Today $4.90 +0.08 (+1.66%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Mirador Capital Partners LP Grows Stake in LifeMD, Inc. (NASDAQ:LFMD)Mirador Capital Partners LP increased its stake in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 139.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 106,059 shares of the company's stock after purchasing an additional 61,73January 16, 2025 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of "Moderate Buy" by AnalystsShares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have earned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendation onJanuary 16, 2025 | marketbeat.comHead to Head Review: SBC Medical Group (NASDAQ:SBC) & LifeMD (NASDAQ:LFMD)January 15, 2025 | americanbankingnews.comLifeMD (NASDAQ:LFMD) Price Target Lowered to $7.00 at KeyCorpJanuary 10, 2025 | americanbankingnews.comLifeMD (NASDAQ:LFMD) Given New $7.00 Price Target at KeyCorpKeyCorp cut their price objective on LifeMD from $10.00 to $7.00 and set an "overweight" rating on the stock in a research report on Wednesday.January 8, 2025 | marketbeat.comJustin Schreiber Sells 25,000 Shares of LifeMD, Inc. (NASDAQ:LFMD) StockJanuary 7, 2025 | insidertrades.comLifeMD, Inc. (NASDAQ:LFMD) CEO Sells $129,750.00 in StockLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) CEO Justin Schreiber sold 25,000 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $5.19, for a total transaction of $129,750.00. Following the sale, the chief executive officer now directly owns 2,703,715 shares in the company, valued at approximately $14,032,280.85. This represents a 0.92 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.January 6, 2025 | marketbeat.comState Street Corp Buys 192,861 Shares of LifeMD, Inc. (NASDAQ:LFMD)State Street Corp boosted its position in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 20.0% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,155,495 shares of the company's stock after acquiring an additional 192,861 shares during the period. State StDecember 29, 2024 | marketbeat.comLifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockDecember 24, 2024 | globenewswire.comLifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Moderate Buy" by BrokeragesShares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven brokerages that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. ThDecember 22, 2024 | marketbeat.comLifeMD (NASDAQ:LFMD) Now Covered by Analysts at Lake Street CapitalLake Street Capital began coverage on shares of LifeMD in a research report on Tuesday. They set a "buy" rating and a $12.00 price objective for the company.December 10, 2024 | marketbeat.comLifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and DistributionDecember 5, 2024 | markets.businessinsider.comLifeMD initiated with a Neutral at MizuhoDecember 4, 2024 | markets.businessinsider.comLifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of "Buy" by AnalystsShares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have received a consensus recommendation of "Buy" from the six analysts that are presently covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 1-year price target amoNovember 27, 2024 | marketbeat.comRoyce & Associates LP Has $4.72 Million Stock Holdings in LifeMD, Inc. (NASDAQ:LFMD)Royce & Associates LP lifted its holdings in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 14.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 901,041 shares of the company's stNovember 19, 2024 | marketbeat.comLos Angeles Capital Management LLC Acquires 108,822 Shares of LifeMD, Inc. (NASDAQ:LFMD)Los Angeles Capital Management LLC boosted its position in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 852.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 121,585 shares of the company's stock afteNovember 17, 2024 | marketbeat.comLifeMD (LFMD) Gets a Buy from Craig-HallumNovember 15, 2024 | markets.businessinsider.comLifeMD to Participate in Three Investor Conferences During NovemberNovember 12, 2024 | markets.businessinsider.comStrong Revenue Growth and Strategic Initiatives Position LifeMD for Continued Expansion Despite ChallengesNovember 11, 2024 | markets.businessinsider.comLifeMD, Inc.: LifeMD Reports Third Quarter 2024 ResultsNovember 11, 2024 | finanznachrichten.deLifeMD (NASDAQ:LFMD) Earns Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $12.00 price target on shares of LifeMD in a report on Monday.November 11, 2024 | marketbeat.comLifeMD, Inc. (LFMD) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comLifeMD backs FY24 revenue view at least $205M, consensus $206MNovember 9, 2024 | markets.businessinsider.comLifeMD price target raised to $12 from $11 at B. RileyNovember 9, 2024 | markets.businessinsider.comLifeMD Reports Third Quarter 2024 ResultsNovember 7, 2024 | globenewswire.comLifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational EfficiencyNovember 6, 2024 | markets.businessinsider.comLifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Buy" from BrokeragesLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has received a consensus rating of "Buy" from the six brokerages that are presently covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts thaNovember 2, 2024 | marketbeat.comLifeMD (LFMD) Scheduled to Post Quarterly Earnings on ThursdayLifeMD (NASDAQ:LFMD) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639696)October 31, 2024 | marketbeat.comLifeMD launches TestoRx, direct to consumer testosterone replacement therapyOctober 23, 2024 | markets.businessinsider.comBuy Rating Affirmed for LifeMD Amid Favorable Compounding Pharmacy Developments and Strong Market PositioningOctober 15, 2024 | markets.businessinsider.comLifeMD Inc (LFMD) Q2 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ...October 9, 2024 | finance.yahoo.comLifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockSeptember 24, 2024 | globenewswire.comLifeMD, Inc. (LFMD)September 22, 2024 | finance.yahoo.comLifeMD (NASDAQ:LFMD) Given "Overweight" Rating at Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and issued a $15.00 price objective on shares of LifeMD in a report on Friday.September 20, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Shares Sold by Divisadero Street Capital Management LPDivisadero Street Capital Management LP cut its position in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 11.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,498,382 shares of the company's stock after selliSeptember 20, 2024 | marketbeat.comInsider Buying: LifeMD, Inc. (NASDAQ:LFMD) Insider Buys 3,000 Shares of StockSeptember 13, 2024 | insidertrades.comLifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of "Buy" by BrokeragesLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six brokerages that are presently covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages thSeptember 13, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Insider Stefan Galluppi Buys 3,000 SharesLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) insider Stefan Galluppi acquired 3,000 shares of the firm's stock in a transaction dated Wednesday, September 11th. The shares were purchased at an average cost of $4.93 per share, with a total value of $14,790.00. Following the completion of the transaction, the insider now owns 45,449 shares in the company, valued at approximately $224,063.57. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.September 12, 2024 | marketbeat.comLifeMD to Participate in Three Investor Conferences During SeptemberAugust 26, 2024 | globenewswire.comCalamos Advisors LLC Acquires Shares of 57,413 LifeMD, Inc. (NASDAQ:LFMD)Calamos Advisors LLC bought a new position in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 57,413 shares of the company's stock, valued at approximatelyAugust 26, 2024 | marketbeat.comLifeMD's (LFMD) "Overweight" Rating Reaffirmed at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating and set a $15.00 target price on shares of LifeMD in a research report on Tuesday.August 20, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Buy" from AnalystsLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month price target among analystsAugust 19, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Short Interest Up 12.9% in JulyLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) saw a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 4,450,000 shares, a growth of 12.9% from the July 15th total of 3,940,000 shares. Currently, 13.2% of the company's shares are sold short. Based on an average daily volume of 895,300 shares, the short-interest ratio is presently 5.0 days.August 18, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Shares Purchased by Vanguard Group Inc.Vanguard Group Inc. raised its holdings in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 12.5% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,155,193 shares of the company's stock after acquiring an additional 128,701 shares during the quarAugust 14, 2024 | marketbeat.comLifeMD (NASDAQ:LFMD) Earns "Overweight" Rating from Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and set a $15.00 price target on shares of LifeMD in a report on Friday.August 9, 2024 | marketbeat.comLifeMD’s Consistent Growth and Margin Improvement Reinforce Buy RatingAugust 8, 2024 | markets.businessinsider.comStrong Growth and Positive Outlook Justify Buy Rating for LifeMDAugust 8, 2024 | markets.businessinsider.comLifeMD Inc LFMDAugust 2, 2024 | morningstar.comLifeMD (LFMD) Scheduled to Post Earnings on WednesdayLifeMD (NASDAQ:LFMD) will be releasing earnings after the market closes on Wednesday, August 7, Zacks reports.July 31, 2024 | marketbeat.comAcadian Asset Management LLC Boosts Stock Position in LifeMD, Inc. (NASDAQ:LFMD)Acadian Asset Management LLC boosted its holdings in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 261.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 116,655 shares of the company's stock after buying an additionalJuly 26, 2024 | marketbeat.com Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address LFMD Media Mentions By Week LFMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFMD News Sentiment▼1.000.44▲Average Medical News Sentiment LFMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFMD Articles This Week▼32▲LFMD Articles Average Week Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Castle Biosciences News Today Auna News Today Grail News Today Fulgent Genetics News Today Talkspace News Today InnovAge News Today DocGo News Today Celcuity News Today Enhabit News Today Personalis News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFMD) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LFMD Stock Alerts